Headline
The latest stories from AHA Today.
FDA revised its April 3 emergency use authorization for N95 and similar respirators made in China to remove certain respirators that failed to demonstrate at least 95% particulate filtration efficiency when tested by the National Institute for Occupational Safety and Health.
The Food and Drug Administration issued an emergency use authorization to Rutgers Clinical Genomics Laboratory for the first COVID-19 diagnostic test with the option of using home-collected saliva samples.
CMS recently issued new Frequently Asked Questions to aid the Medicaid program and Children's Health Insurance Program in their response to the COVID-19 pandemic.
AHA urged the Federal Communications Commission to grant expedited approval to its request that the agency extend the COVID-19 Telehealth Program to all hospitals and other direct patient care facilities, regardless of their size, location, or for-profit or not-for-profit status.
A federal district court in Washington, D.C., heard oral argument in the AHA’s legal challenge to the Centers for Medicare & Medicaid Services’ final rule mandating that hospitals disclose their privately negotiated charges with commercial health insurers.
Sens. Lisa Murkowski, R-Alaska, Michael Bennett, D-Colo., and Dan Sullivan, R-Alaska, introduced AHA-supported legislation (S. 3615) that would extend for five years the Medicare Rural Community Hospital Demonstration Program.
Hospitals and health systems are designing new digital response strategies in the battle against COVID-19. What lessons have been learned so far, and which digital response methods are most successful?
As the nation celebrates National Nurses Week in the midst of the COVID-19 pandemic, nurses' commitment and strength is inspiring communities across the country and their leadership is essential, writes AHA President and CEO Rick Pollack in a special message to the American Organization for Nursing…
To streamline the reporting of COVID-19 lab test results, the CDC encouraged all U.S. hospital laboratories to submit their COVID-19 testing information to their state or local public health department following their normal protocol for reportable conditions.
The Department of Health and Human Services released updated FAQs related to payments from the Public Health and Social Services Emergency Fund.